TITLE

Binding of anti-inflammatory drug indomethacin with cyclodextrin and DNA: solubility, spectroscopic, and voltammetric studies

AUTHOR(S)
Shehatta, I S; Ibrahim, M S
PUB. DATE
October 2001
SOURCE
Canadian Journal of Chemistry;Oct2001, Vol. 79 Issue 10, p1431
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The interaction of the anti-inflammatory drug indomethacin (IMC) with α-, β-cyclodextrins (CDs) and calf thymus deoxyribonucleic acid (ct-DNA) have been investigated in the Britton-Robinson (BR) buffer (pH = 7.2) using solubility, spectroscopic, and voltammetric methods. The measurements show that the IMC molecule, acting as an intercalator, is inserted, from the p-chlorobenzoyl part, into the cavity of the cyclodextrins as well as into the base-stacking domain of the ct-DNA double helix. Upon addition of β-CD in a buffered IMC solution, the solubility of IMC increases and the Gibbs free energies of transfer of the drug from aqueous solution to the cavity of β-CD are negative and increase negatively with increasing β-CD concentration. The interaction of IMC with CDs and ct-DNA causes hypochromism and bathochromic shifts in the absorption spectra, along with pronounced changes in the electrochemical behaviour of the drug. The stoichiometry of complexes formed in solution is inferred to be 1:1. The binding constants were calculated from the increase of the solubility, the strong hypochromism, and the decrease in peak current of IMC upon the addition of the host molecules. IMC has a higher affinity for β-CD than for α-CD, as the IMC–β-CD interaction is the most exergonic. Binding is interpreted in terms of the intercalative (hydrophobic) interactions with the ct-DNA helix (i.e., the stacked base pairs) or within CD cavity.Key words: cyclodextrin, ct-DNA, anti-inflammatory drug, indomethacin, binding constant, solubility, spectra, voltammetry.Faisant appel à des méthodes basées sur la solubilité, la spectroscopie et la voltampérométrie et opérant dans un tampon de Britton-Robinson (BR) (pH = 7,2), on a étudié l'interaction entre l'indométhacine (IMC), un antiinflammatoire, et les α- et β-cyclodextrines (CD) et l'acide désoxyribonucléique de la thyroïde du veau (ct-DNA). Les mesures montrent que la molécule d'IMC s'intercale, à partir de la portion p-chlorobenzoyle, dans la cavité des cyclodextrines ainsi que dans le domaine d'empilement des bases de la double hélice du ct-DNA. Par addition de β-CD dans une solution tamponnée d'IMC, la solubilité de l'IMC augmente; les énergies libres de Gibbs du transfert du médicament à partir de la solution aqueuse vers la cavité de la β-CD sont négatives et elles augmentent de façon négative avec une augmentation de la concentration de β-CD. L'interaction de l'IMC avec les CD et le ct-DNA provoque une hypochromie et une bathochromie dans les spectres d'absorption et des changements importants dans le comportement électrochimique du médicament. On fait l'hypothèse que la stoechiométrie des complexes qui se forment en solution est 1:1. Les constantes de fixation ont été calculées à partir de l'augmentation de la solubilité, la forte hypochromie et la diminution du courant de sommet de l'IMC lors de l'addition de molécules hôtes. L'affinité de l'IMC est plus grande pour la β-CD que pour la α-CD parce que l'interaction IMC–β-CD est la plus exergonique. La fixation est interprétée en termes de la facilité des interactions d'intercalation (hydrophobes) dans l'hélice de la ct-DNA (c'est-à-dire les paires de bases empilées) ou à l'intérieur de la cavité de la CD.Mots clés : cyclodextrine, ct-DNA, médicament antiinflammatoire, indométhacine, constante de fixation, solubilité, spectres, voltampérométrie.[Traduit par la Rédaction]
ACCESSION #
10577084

 

Related Articles

  • Indomethacin—Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization. Srinivas Basavoju; Dan Boström; Sitaram Velaga // Pharmaceutical Research;Mar2008, Vol. 25 Issue 3, p530 

    Abstract Purpose  To design and prepare cocrystals of indomethacin using crystal engineering approaches, with the ultimate objective of improving the physical properties of indomethacin, especially solubility and dissolution rate. Materials and Methods  Various cocrystal formers,...

  • Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA. Arima, Hidetoshi; Motoyama, Keiichi; Higashi, Taishi // Pharmaceutics;Mar2012, Vol. 4 Issue 1, p130 

    Gene, short hairpin RNA (shRNA) and small interfering RNA (siRNA) delivery can be particularly used for the treatment of diseases by the entry of genetic materials mammalian cells either to express new proteins or to suppress the expression of proteins, respectively. Polyamidoamine (PAMAM)...

  • Endothelin-1-dependent up-regulation of leptin production in gastric mucosal injury by indomethacin. Slomiany, Bronislaw L.; Slomiany, Amalia // Inflammopharmacology;2005, Vol. 13 Issue 5/6, p455 

    Leptin, a multifunctional hormone that regulates food intake and metabolic and endocrine responses, has emerged recently as an important modulatory factor in gastric mucosal resistance to injury. In this study, we applied the animal model of gastric mucosal injury caused by indomethacin to...

  • The peroxisome proliferator-activated receptor α activator, Wy14,643, is anti-inflammatory in vivo. Colville-Nash, Paul; Willis, Dean; Papworth, Jonathan; Freemantle, Claire; Lam, Connie; Andrews, Gemma; Willoughby, Derek // Inflammopharmacology;2005, Vol. 12 Issue 5/6, p493 

    The peroxisome proliferator-activated receptor system is exciting much interest as a novel point of therapeutic intervention in inflammation. Here, the effect of a peroxisome proliferator-activated receptor α agonist, [4-chloro-6-(2,3-xylidine)-pyrimidinylthio]acetic acid (Wy14,643), was...

  • High Sensitivity of Gastric Mucosa to Ulcerogenic Effect of Indomethacin in Rats with Diabetes. Podvigina, T.; Bagaeva, T.; Bobryshev, P.; Filaretova, L. // Bulletin of Experimental Biology & Medicine;Nov2011, Vol. 152 Issue 1, p43 

    One week after injection of streptozotocin (60 mg/kg intravenously), rats developed diabetes associated with a significant increase of gastric mucosa sensitivity to the ulcerogenic effect of indomethacin (35 mg/kg subcutaneously). Since potentiation of the ulcerogenic effect of indomethacin was...

  • Solid Lipid Nanoparticles as Indomethacin Carriers for Topical Use (2): DSC Analysis, Drug Release and Rheological Properties. Amara, Hend M. Abu // Jordan Journal of Pharmaceutical Sciences;Aug2014, Vol. 7 Issue 2, p97 

    Solid lipid nanoparticles (SLNs) and nano structured lipid carriers (NLCs) containing or not containing indomethacin (IND) were prepared with either Cetyl palmitate, Geleol™, or Compritol® 888 ATO as a lipid phase by the hot homogenization technique. In all systems the surfactant was...

  • Bone mineral density and bone turnover in patients with Bartter syndrome. Rodr&x00ED;guez-Soriano, Juan; Vallo, Alfredo; Aguirre, Mireia // Pediatric Nephrology;Aug2005, Vol. 20 Issue 8, p1120 

    The aim of this investigation was to evaluate bone mineral density (BMD), by use of DXA, and bone turnover, in patients with Bartter syndrome (BS). Ten patients (2 with BS type II and 8 with BS type III) were included in the procedure. Age at study varied between 2 and 30 years. During the...

  • Ductal Closure In An Extremely Low Birth Weight Premature Infant. Elmistekawy, Elsayed; Syed, Aitizaz U.; Fawzy, Hossam A.; Marzook, Mahmood; Darwish, Hassan // Internet Journal of Thoracic & Cardiovascular Surgery;2006, Vol. 8 Issue 1, p12 

    Surgical closure of patent ductus arteriousus (PDA) is indicated in premature infants with very low birth weight specially who have a contraindication to or have been failed a trial of indomethacin therapy. We report surgical ligation of patent ductus arteriousus in an extremely very low birth...

  • DICHOTOMY IN RESPONSE TO INDOMETHACIN IN UV-C and UV-B INDUCED ULTRAVIOLET LIGHT INFLAMMATION. Eaglstein, William H.; Marsico, Albert R. // Journal of Investigative Dermatology;Aug75, Vol. 65 Issue 2, p238 

    In subjects irradiated with both UV-C and UV-B ultraviolet light (UVL), 10 μg of intradermal indomethacin decreased the redness in all 13 of the UV-B irradiated areas but in only 2 of 13 of the UV-C irradiated areas. Higher doses of' intradermal indomethacin (50 μg and 100 μg) decreased...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics